Home - Emerging Leaders in Inflammatory Skin Diseases 2027

Dermatology is a growing field with emerging therapies and increasing treatment costs. Healthcare institutions are undergoing tremendous disruption and change, necessitating a diverse array of leaders to be involved in decision-making processes. This course, Emerging Leaders in Inflammatory Skin Diseases is designed to empower executive leaders in dermatology to leverage their strengths, acquire the skills needed for authoritative influence, negotiate effectively, conduct challenging conversations, efficiently lead conflict resolution, and implement and maintain necessary changes in their work and life environments.

There are 25 spaces open for junior or mid-career academic or clinical leaders in inflammatory skin diseases. Course tuition fees will be provided for successful applicants. Application deadline January 31. To learn more about eligibility or to submit an application to attend, see here.

Meghan Agnew, MBA

Vice-President & Chief Financial Officer, Harvard Medical Faculty Physicians at BIDMC

Afsaneh Alavi, MD

Professor of Dermatology, Mayo Clinic; Director of Medical Dermatology Fellowship

Kristen Beech, Esq.

Chief Legal Officer and Vice President, Harvard Medical Faculty Physicians at BIDMC

Eva Cullen, Ph.D

Vice President Medical Affairs and Research, MoonLake Immunotherapeutics

Dawn Davis, MD

Dawn Davis, M.D. Professor of Dermatology and Pediatrics, Mayo Clinic Rochester

Mercedes Diz

CEO, Highlight Therapeutics

Esther E. Freeman, MD, PhD, DTM&H

Director, Global Health Dermatology, MGH

Melinda Gooderham, MD

Medical Director, SKiN Centre for Dermatology

Shlomit Halachmi, MD, PhD

Founder and CEO, Building 66 LLC

Alexa Kimball, MD, MPH

CEO and President, Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center

Amy McMichael, MD, FAAD

Professor of Dermatology, Wake Forest University School of Medicine

Susan Hamilton Meier

Founder & Principal, Susan Meier Studio

Amy Paller, MS, MD

Professor and Chair of Dermatology, Professor of Pediatrics, Northwestern

Adam Rodman, MD

Director of AI Programs & Director of Foundations in Digital Education, BIDMC

Vivian Y. Shi, MD, FAAD

Founding Director of Clinical Trials, University of Washington

Kanade Shinkai, MD, PhD

Professor of Dermatology and VP of Academic Affairs, UCSF Department of Dermatology

Olayemi Sokumbi, MD

Professor of Dermatology and Lab Medicine & Pathology, Mayo Medical School

Ruth Ann Vleugels, MD, MPH, MBA

Chair, Dermatology, Penn State

Madalena Wozniak, MSc, PhD

Clinical Development Director, Novartis

Upon completion of this activity, participants will be able to:

Employ techniques for leading with impact
Discuss best practices and strategies to address diversity, gender issues and equity as a healthcare leader
Use effective methods for navigating change in the healthcare setting within the field of dermatology
Discuss innovative strategies for building resilience and managing stress in high pressure dermatology settings
Understand how to build on your strengths as a leader yielding positive performance
Understand best practices on conflict negotiation, providing feedback, confronting challenging conversations, leading to avoid physician burn out of employees
Employ best practices in order to achieve financial literacy and key competencies for clinical trial and conflict negotiations
Discuss best practices for leadership in the clinical research environment
Employ techniques for effectively using storytelling to communicate with impact
Discuss how to best support others in leadership and effectively engage our community with the goal of improving the landscape of leadership within the field of dermatology